Clinical Trial Detail

NCT ID NCT04391595
Title LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Nader Sanai
Indications

malignant glioma

Therapies

Abemaciclib + LY3214996

Age Groups: adult senior

Additional content available in CKB BOOST